Howard Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Howard Financial Services's AZN Position: Q3 2026 in Review
Howard Financial Services increased its AstraZeneca (AZN) stake by 1.3% in Q3 2026, buying an estimated $4.5K and bringing the position to 2,147 shares worth $347K. The position accounts for 0.04% of the portfolio, ranked #166.
Howard Financial Services first reported a position in AZN in Q2 2022 and has held it in 17 quarters since. The position peaked at $585K in Q2 2023. 1,444 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Howard Financial Services held 2,147 shares of AstraZeneca worth $347K as of Q3 2026.
- Howard Financial Services bought 27 AstraZeneca shares in Q3 2026, an estimated $4.5K.
- AstraZeneca made up 0.04% of Howard Financial Services's portfolio in Q3 2026, its #166 holding.
- Howard Financial Services first reported a position in AstraZeneca in Q2 2022 and has held it in 17 quarters since.
- Howard Financial Services's AstraZeneca position peaked at $585K in Q2 2023.
- 1,444 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Howard Financial Services's 13F filing for Q3 2026, filed 15 Oct 2026.